StockWatch
·
Medical/Dental Instruments
Quarterly ResultMay 8, 2026, 04:07 PM

LENSAR Q1 Net Income $36.3M; EPS $1.56; Merger Terminated

AI Summary

LENSAR, Inc. reported a significant financial turnaround in Q1 2026, achieving a net income of $36.3 million and basic EPS of $1.56, compared to substantial losses in the prior year. This improvement was largely driven by the termination of its Merger Agreement with Alcon, which resulted in LENSAR retaining a $10.0 million cash deposit and a favorable change in the fair value of warrant liabilities. Despite a slight decrease in total revenue to $13.4 million, the company also improved its operating income and strengthened its stockholders' equity.

Key Highlights

  • Merger Agreement with Alcon terminated on March 16, 2026.
  • Q1 2026 net income was $36.3 million, a significant improvement from a $27.3 million net loss in Q1 2025.
  • Basic EPS for Q1 2026 was $1.56, up from a loss of $2.32 per share in Q1 2025.
  • LENSAR retained a $10.0 million cash deposit from the terminated merger, recorded as acquisition-related income.
  • Total revenue decreased to $13.4 million in Q1 2026 from $14.2 million in Q1 2025.
  • Operating income improved to $2.2 million in Q1 2026 from an operating loss of $5.8 million in Q1 2025.
  • Total stockholders' equity improved to $10.8 million at March 31, 2026, from a $26.0 million deficit.
  • Entered into a Priority Credit Line Agreement with Wells Fargo in March 2026.